Nov 25, 2017 AM EST - Maureen Santos

FDA Approved Juluca, GlaxoSmithKline's New Two-Drug Combination to Treat HIV Virus

A new drug will soon be available in the market to treat HIV virus. Viiv is the manufacturer of the new medicine with the combination of dolutegravir, and rilpivirine and is named Juluca.